Related Experiment Video
Updated: Jan 14, 2026
Dry Powder and Nebulized Aerosol Inhalation of Pharmaceuticals Delivered to Mice Using a Nose-only Exposure System
Published on: April 6, 2017
Delivery of L-Epinephrine by Metered-Dose Inhaler Compared to Racemic Epinephrine by Nebulizer for the Treatment of
Brian Novi1, Kimberly Kahne2, Cassidy Psihos1
1Department of Pediatric Emergency Medicine, Cohen Children's Medical Center, Northwell Health, New Hyde Park, New York.
Background:
Racemic epinephrine is standard of care for moderate to severe croup. Metered-dose inhaler (MDI) was the most adopted method to replace nebulization during the SARS-CoV-2 pandemic. No study has previously evaluated the effectiveness of l-epinephrine MDI for the treatment of croup in an emergency department as compared to nebulized racemic epinephrine.
Objective:
We aim to demonstrate that l-epinephrine by MDI is effective and safe in the treatment of croup compared to racemic epinephrine. Our primary outcome was the requirement of additional doses of epinephrine.
Methods:
We conducted a retrospective, single-center study of pediatric patients 1-10 years of age diagnosed with croup from March 2020 to July 2023. We included patients who received either l-epinephrine metered-dose inhaler (LEM) or racemic epinephrine by nebulization (REN) for the treatment of croup. Data for l-epinephrine was collected prospectively.
Results:
There were 325 patients analyzed of which patients in 38 encounters were treated with LEM. The median age for patients was 2.6 years (IQR: 1.6, 4.4) and 75% were male. Respiratory viral testing revealed 14% positive for SARS-CoV-2. Patients that received LEM showed an improvement in Westley Croup Score (WCS) of 2 (IQR: -3, -2) at 30 minutes post-administration. When comparing LEM to REN, there was no statistical difference in need for repeat dosing, change in heart rate, return to care within 48 hours, or admission to the hospital.
Conclusion:
In this study of l-epinephrine administered by MDI we did not observe any statistically significant differences compared to nebulized racemic epinephrine in the treatment of croup.
Related Concept Videos
01:23Inhaled Medications
01:28Adrenergic Agonists: Mixed-Action Agents
Ephedrine and pseudoephedrine lack a catecholamine group, making them less susceptible to degradation by metabolic enzymes. They have increased oral bioavailability and lipophilicity, resulting in a longer duration of action. Their response is reduced by...
01:30Adrenergic Agonists: Therapeutic Uses
Emergency and Intensive Care Unit (ICU) applications: Pressor agents increase blood pressure, heart rate, and contractility in shock and organ failure situations. Dopamine can induce vasodilation and stimulate adrenoceptors. Endogenous catecholamines are effective in treating cardiogenic shock. α2-agonists like clonidine can reverse anesthesia-induced hypertension.
Allergies and...
01:30Asthma-IV: Diagnostic and Management
Clinical Assessment for Asthma:
This is the first step in diagnosing and managing asthma. It includes:
01:25Antiasthma Drugs: β2-Adrenoceptor Agonists
One class of bronchodilators includes β2-adrenoceptor agonists. These agents target the β2-adrenoceptors located on bronchial smooth muscle cells. By stimulating these receptors, β2-agonists induce...
01:17Drugs Used in Lower Respiratory Disorders: Overview
Bronchodilators, the first step of respiration enhancement, come in various forms, each with its own mechanism...